A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...

A long list of cancer treatment drugs are in short supply, prompting doctors to make difficult decisions about how they treat their patients. According to the FDA, 14 drugs used for chemotherapy are ...

Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...

Mayo Clinic researchers say they have discovered that ovarian cancer cells can quickly activate a survival response after treatment with PARP inhibitors.

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this ...

Finge medical groups once touted ivermectin as an effective COVID-19 treatment. But studies did not find that to be true, and there's no new evidence to suggest it can fight cancer, either.

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of ...

The National Cancer Institute is studying ivermectin as a potential cancer treatment, according to its top official, alarming career scientists.